{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:04:35Z","timestamp":1763748275544,"version":"3.45.0"},"posted":{"date-parts":[[2025,11,21]]},"group-title":"In Review","reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21 TW011365"],"award-info":[{"award-number":["1R21 TW011365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,21]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\nVideo directly observed treatment (VDOT) supports person-centered care and addresses shortcomings of in-person directly observed treatment (DOTS). However, there is limited literature on implementation costs to inform TB program policy in low-resource settings, such as Uganda.\nObjective\nThis study aimed to assess the costs associated with implementing the VDOT intervention in Uganda, based on a completed randomized trial.\nMethods\nWe carried out a micro-costing analysis. This employed both bottom-up and top-down approaches to estimate health system costs (in 2024 US dollars) of the VDOT intervention. The analysis covered 71 persons with TB from six health facilities in Kampala, Uganda.\nResults\nThe estimated overall costs for implementing VDOT in Uganda were $16,037.80 among 71 patients with TB. The estimated per-person costs for VDOT were $220.93. The largest proportion of the overall cost was associated with smartphones and accessories (29.5%), followed by VDOT platform infrastructure costs (21.7%), program support costs (19.5%), and internet data costs used by patients to send the videos (10.2%). The per-person costs of using VDOT are lower than the potential cost of daily transport that would be associated with facility-based DOT.\nConclusion\nThe implementation of VDOT in Kampala was associated with a relatively low cost compared to the projected cost when using the traditional DOT method. This highlights the cost saving benefit to the patients when using remote treatment monitoring with the video technology. A full economic evaluation from the programmatic and societal perspective is recommended to inform the adoption of the VDOT strategy in resource-limited settings.<\/p>","DOI":"10.21203\/rs.3.rs-7911005\/v1","type":"posted-content","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:48:36Z","timestamp":1763747316000},"source":"Crossref","is-referenced-by-count":0,"title":["A Cost Analysis of Implementing Asynchronous Video Directly Observed Therapy for Monitoring Treatment in Patients with Tuberculosis Disease in Uganda"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1895-9255","authenticated-orcid":false,"given":"Wilson","family":"Tumuhumbise","sequence":"first","affiliation":[{"name":"Faculty of Computing and Informatics, Mbarara University of Science and Technology, Mbarara, Uganda, African Health Informatics Research Institute, Digital Health Division, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Kuteesa","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-6991","authenticated-orcid":false,"given":"Damalie","family":"Nakkonde","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-8027","authenticated-orcid":false,"given":"Esther","family":"Buregyeya","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9539-6110","authenticated-orcid":false,"given":"Sarah","family":"Zalwango","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University, Kampala, Uganda, Kampala Capital City Authority, Department of Public Health Service and Environment, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-696X","authenticated-orcid":false,"given":"Angella","family":"Musiimenta","sequence":"additional","affiliation":[{"name":"Faculty of Computing and Informatics, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-1396","authenticated-orcid":false,"given":"Juliet N.","family":"Sekandi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA\/USA, Global Health Institute, College of Public Health, University of Georgia, Athens, GA\/USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO Tuberculosis 2024 [cited 2025 7th Feb ]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis"},{"key":"ref2","first-page":"1","article-title":"Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study","volume":"21","author":"Chen X","year":"2021","unstructured":"Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y et al (2021) Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health 21:1\u201310","journal-title":"BMC Public Health"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1186\/s12889-023-16259-6","article-title":"Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient\u2019s perspective","volume":"23","author":"Appiah MA","year":"2023","unstructured":"Appiah MA, Arthur JA, Gborgblorvor D, Asampong E, Kye-Duodu G, Kamau EM et al (2023) Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient\u2019s perspective. BMC Public Health 23(1):1317","journal-title":"BMC Public Health"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2147\/PPA.S370520","article-title":"Factors influencing treatment adherence among drug-sensitive tuberculosis (DS-TB) patients in Armenia: a qualitative study","author":"Grigoryan Z","year":"2022","unstructured":"Grigoryan Z, McPherson R, Harutyunyan T, Truzyan N, Sahakyan S (2022) Factors influencing treatment adherence among drug-sensitive tuberculosis (DS-TB) patients in Armenia: a qualitative study. Patient Prefer Adherence. :2399\u20132408","journal-title":"Patient Prefer Adherence"},{"issue":"10455","key":"ref5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(24)01609-X","article-title":"HIV and tuberculosis in Uganda: are we neglecting poverty?","volume":"404","author":"Kizito S","year":"2024","unstructured":"Kizito S, Nabayinda J, Nabunya P, Ssewamala FM (2024) HIV and tuberculosis in Uganda: are we neglecting poverty? Lancet 404(10455):844\u2013845","journal-title":"Lancet"},{"key":"ref6","author":"WHO_Uganda","unstructured":"WHO_Uganda Uganda Government reiterates commitment to end TB by 2030 2023 [cited 2025 15th July]. Available from: https:\/\/www.afro.who.int\/countries\/uganda\/news\/uganda-government-reiterates-commitment-end-tb-2030"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"e1001675","DOI":"10.1371\/journal.pmed.1001675","article-title":"Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru","volume":"11","author":"Wingfield T","year":"2014","unstructured":"Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R et al (2014) Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 11(7):e1001675","journal-title":"PLoS Med"},{"key":"ref8","volume-title":"Global Tuberculosis Report 2022","author":"WHO","year":"2022","unstructured":"WHO (2022) Global Tuberculosis Report 2022. World Health Organization"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4269\/ajtmh.19-0848","article-title":"Out-of-pocket costs for patients diagnosed with tuberculosis in different healthcare settings in Bandung, Indonesia","volume":"103","author":"McAllister SM","year":"2020","unstructured":"McAllister SM, Lestari BW, Sullivan T, Hadisoemarto PF, Afifah N, Apip RA et al (2020) Out-of-pocket costs for patients diagnosed with tuberculosis in different healthcare settings in Bandung, Indonesia. Am J Trop Med Hyg 103(3):1057","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial burden for tuberculosis patients in low-and middle-income countries: a systematic review","volume":"43","author":"Tanimura T","year":"2014","unstructured":"Tanimura T, Jaramillo E, Weil D, Raviglione M, L\u00f6nnroth K (2014) Financial burden for tuberculosis patients in low-and middle-income countries: a systematic review. Eur Respir J 43(6):1763\u20131775","journal-title":"Eur Respir J"},{"key":"ref11","unstructured":"WHO Eliminating financial and economic barriers to tuberculosis diagnosis 2018 [cited 2025 7th February]. Available from: https:\/\/www.who.int\/news\/item\/17-12-2018-eliminating-financial-and-economic-barriers-to-tuberculosis-diagnosis-and-care"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid P","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A et al (2016) Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63(7):e147\u2013e95","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"100093","DOI":"10.1016\/j.jctube.2019.100093","article-title":"Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS)","volume":"15","author":"Salehitali S","year":"2019","unstructured":"Salehitali S, Noorian K, Hafizi M, Dehkordi AH (2019) Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS). J Clin Tuberculosis Other Mycobact Dis 15:100093","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"key":"ref14","first-page":"6","article-title":"Challenges in tuberculosis care in Western Uganda: health care worker and patient perspectives","volume":"1","author":"Wynne A","year":"2014","unstructured":"Wynne A, Richter S, Banura L, Kipp W (2014) Challenges in tuberculosis care in Western Uganda: health care worker and patient perspectives. Int J Afr Nurs Sci 1:6\u201310","journal-title":"Int J Afr Nurs Sci"},{"key":"ref15","first-page":"e54117","article-title":"Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines","volume":"11","author":"Leung CL","year":"2024","unstructured":"Leung CL, Alacapa J (2024) Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines. Qualitative Interview Study 11:e54117","journal-title":"Qualitative Interview Study"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"e57991","DOI":"10.2196\/57991","article-title":"Effectiveness of a Mobile Health Intervention (DOT Selfie) in Increasing Treatment Adherence Monitoring and Support for Patients With Tuberculosis in Uganda: Randomized Controlled Trial","volume":"13","author":"Sekandi JN","year":"2025","unstructured":"Sekandi JN, Buregyeya E, Zalwango S, Nakkonde D, Kaggwa P, Quach THT et al (2025) Effectiveness of a Mobile Health Intervention (DOT Selfie) in Increasing Treatment Adherence Monitoring and Support for Patients With Tuberculosis in Uganda: Randomized Controlled Trial. JMIR mHealth uHealth 13(1):e57991","journal-title":"JMIR mHealth uHealth"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"100119","DOI":"10.1016\/j.jctube.2019.100119","article-title":"Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study","volume":"17","author":"Musiimenta A","year":"2019","unstructured":"Musiimenta A, Tumuhimbise W, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D et al (2019) Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study. J Clin tuberculosis other Mycobact Dis 17:100119","journal-title":"J Clin tuberculosis other Mycobact Dis"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/QAD.0000000000001021","article-title":"Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda","volume":"30","author":"Haberer JE","year":"2016","unstructured":"Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC et al (2016) Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids 30(8):1295\u20131299","journal-title":"Aids"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jval.2021.12.002","article-title":"Cost and cost-effectiveness of a digital adherence technology for tuberculosis treatment support in Uganda","volume":"25","author":"Thompson RR","year":"2022","unstructured":"Thompson RR, Kityamuwesi A, Kuan A, Oyuku D, Tucker A, Ferguson O et al (2022) Cost and cost-effectiveness of a digital adherence technology for tuberculosis treatment support in Uganda. Value Health 25(6):924\u2013930","journal-title":"Value Health"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00175-2019","article-title":"Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study","volume":"6","author":"Sekandi JN","year":"2020","unstructured":"Sekandi JN, Buregyeya E, Zalwango S, Dobbin KK, Atuyambe L, Nakkonde D et al (2020) Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study. ERJ open Res. ;6(1)","journal-title":"ERJ open Res"},{"issue":"6","key":"ref21","first-page":"779","article-title":"Videophone utilization as an alternative to directly observed therapy for tuberculosis","volume":"14","author":"Krueger K","year":"2010","unstructured":"Krueger K, Ruby D, Cooley P, Montoya B, Exarchos A, Djojonegoro B et al (2010) Videophone utilization as an alternative to directly observed therapy for tuberculosis. Int J Tuberc Lung Dis 14(6):779\u2013781","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2105\/AJPH.2020.305877","article-title":"Cost of tuberculosis therapy directly observed on video for health departments and patients in New York City; San Francisco, California; and Rhode Island (2017\u20132018)","volume":"110","author":"Beeler Asay GR","year":"2020","unstructured":"Beeler Asay GR, Lam CK, Stewart B, Mangan JM, Romo L, Marks SM et al (2020) Cost of tuberculosis therapy directly observed on video for health departments and patients in New York City; San Francisco, California; and Rhode Island (2017\u20132018). Am J Public Health 110(11):1696\u20131703","journal-title":"Am J Public Health"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Garfein RS, Liu L, Cepeda J, Graves S, San Miguel S, Antonio A et al (eds) (2024) Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled Trial. Open Forum Infectious Diseases; : Oxford University Press US","DOI":"10.1093\/ofid\/ofae180"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"e18029","DOI":"10.2196\/18029","article-title":"Using a mobile health intervention (DOT selfie) with transfer of social bundle incentives to increase treatment adherence in tuberculosis patients in Uganda: protocol for a randomized controlled trial","volume":"10","author":"Sekandi JN","year":"2021","unstructured":"Sekandi JN, Onuoha NA, Buregyeya E, Zalwango S, Kaggwa PE, Nakkonde D et al (2021) Using a mobile health intervention (DOT selfie) with transfer of social bundle incentives to increase treatment adherence in tuberculosis patients in Uganda: protocol for a randomized controlled trial. JMIR Res protocols 10(1):e18029","journal-title":"JMIR Res protocols"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3201\/eid2410.180459","article-title":"Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA","volume":"24","author":"Garfein RS","year":"2018","unstructured":"Garfein RS, Liu L, Cuevas-Mota J, Collins K, Mu\u00f1oz F, Catanzaro DG et al (2018) Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA. Emerg Infect Dis 24(10):1806","journal-title":"Emerg Infect Dis"},{"key":"ref26","unstructured":"StopTB_Partnership Costing Tool -Wave 6 Digital Adherence Technology Projects 2020 [cited 2025 6th July ]. Available from: https:\/\/stoptb.org\/assets\/documents\/global\/awards\/tbreach\/DAT%20costing%20tool_V2.pdf"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3201\/eid3001.230427","article-title":"Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018\u20132021","volume":"30","author":"Nsengiyumva NP","year":"2024","unstructured":"Nsengiyumva NP, Khan A, Gler MMTS, Tonquin ML, Marcelo D, Andrews MC et al (2024) Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018\u20132021. Emerg Infect Dis 30(1):79","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1186\/s12913-023-10295-z","article-title":"Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda","volume":"23","author":"Rosu L","year":"2023","unstructured":"Rosu L, Madan J, Bronson G, Nidoi J, Tefera MG, Malaisamy M et al (2023) Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda. BMC Health Serv Res 23(1):1275","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015654","article-title":"Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review","volume":"9","author":"Kafie C","year":"2024","unstructured":"Kafie C, Mohamed MS, Zary M, Chilala CI, Bahukudumbi S, Gore G et al (2024) Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review. BMJ global health. ;9(10)","journal-title":"BMJ global health"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"e0004454","DOI":"10.1371\/journal.pgph.0004454","article-title":"Examining the challenges in sustaining user engagement with a mobile app to enhance multidrug-resistant tuberculosis (MDR-TB) care in Vietnam and its implications for implementing person-centred mHealth interventions","volume":"5","author":"Drabarek D","year":"2025","unstructured":"Drabarek D, Trinh-Hoang D, Yapa M, Dang TT, Vu HD, Nguyen TA et al (2025) Examining the challenges in sustaining user engagement with a mobile app to enhance multidrug-resistant tuberculosis (MDR-TB) care in Vietnam and its implications for implementing person-centred mHealth interventions. PLOS Global Public Health 5(4):e0004454","journal-title":"PLOS Global Public Health"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13012-024-01400-9","article-title":"Enhancing the implementation and integration of mHealth interventions in resource-limited settings: a scoping review","volume":"19","author":"Tumuhimbise W","year":"2024","unstructured":"Tumuhimbise W, Theuring S, Kaggwa F, Atukunda EC, Rubaihayo J, Atwine D et al (2024) Enhancing the implementation and integration of mHealth interventions in resource-limited settings: a scoping review. Implement Sci 19(1):72","journal-title":"Implement Sci"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12889-019-7892-9","article-title":"Requiring smartphone ownership for mHealth interventions: who could be left out?","volume":"20","author":"Bommakanti KK","year":"2020","unstructured":"Bommakanti KK, Smith LL, Liu L, Do D, Cuevas-Mota J, Collins K et al (2020) Requiring smartphone ownership for mHealth interventions: who could be left out? BMC Public Health 20(1):81","journal-title":"BMC Public Health"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"e001018","DOI":"10.1136\/bmjgh-2018-001018","article-title":"Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities","volume":"3","author":"Subbaraman R","year":"2018","unstructured":"Subbaraman R, de Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE et al (2018) Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ global health 3(5):e001018","journal-title":"BMJ global health"},{"key":"ref34","volume-title":"Quick guide to video-supported treatment of tuberculosis, World Health Organization","author":"WHO","year":"2020","unstructured":"WHO (2020) Quick guide to video-supported treatment of tuberculosis, World Health Organization. Quick guide to video-supported treatment of tuberculosis"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"e27131","DOI":"10.2196\/27131","article-title":"Stakeholders\u2019 perceptions of benefits of and barriers to using video-observed treatment for monitoring patients with tuberculosis in Uganda: exploratory qualitative study","volume":"9","author":"Sekandi JN","year":"2021","unstructured":"Sekandi JN, Kasiita V, Onuoha NA, Zalwango S, Nakkonde D, Kaawa-Mafigiri D et al (2021) Stakeholders\u2019 perceptions of benefits of and barriers to using video-observed treatment for monitoring patients with tuberculosis in Uganda: exploratory qualitative study. JMIR mHealth uHealth 9(10):e27131","journal-title":"JMIR mHealth uHealth"},{"issue":"10","key":"ref36","first-page":"e27131","article-title":"Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda","volume":"9","author":"Sekandi JN","year":"2021","unstructured":"Sekandi JN, Kasiita V (2021) Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda. Exploratory Qualitative Study 9(10):e27131","journal-title":"Exploratory Qualitative Study"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3390\/s24082455","article-title":"The Advantage of the 5G Network for Enhancing the Internet of Things and the Evolution of the 6G Network","volume":"24","author":"Gkagkas G","year":"2024","unstructured":"Gkagkas G, Vergados DJ, Michalas A, Dossis M (2024) The Advantage of the 5G Network for Enhancing the Internet of Things and the Evolution of the 6G Network. Sensors 24(8):2455","journal-title":"Sensors"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"100417","DOI":"10.1016\/j.invent.2021.100417","article-title":"A review of mobile health interventions for public private mix in tuberculosis care","volume":"25","author":"Tumuhimbise W","year":"2021","unstructured":"Tumuhimbise W, Musiimenta A (2021) A review of mobile health interventions for public private mix in tuberculosis care. Internet interventions 25:100417","journal-title":"Internet interventions"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5588\/ijtld.18.0625","article-title":"Cost savings associated with video directly observed therapy for treatment of tuberculosis","volume":"23","author":"Lam C","year":"2019","unstructured":"Lam C, Fluegge K, Macaraig M, Burzynski J (2019) Cost savings associated with video directly observed therapy for treatment of tuberculosis. Int J Tuberc Lung Dis 23(11):1149\u20131154","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref40"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7911005\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7911005\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:48:42Z","timestamp":1763747322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7911005\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":40,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7911005\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,11,21]]},"subtype":"preprint"}}